The synuclein family

Genome Research

Volumn 8, Issue 9, 1998, Pages 871-880

  Lavedan, Christian ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN; SYNUCLEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BREAST CARCINOMA; GENE EXPRESSION; HUMAN; NERVE DEGENERATION; NUCLEOTIDE SEQUENCE; OVARY CANCER; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SEQUENCE HOMOLOGY;

EID: 0031763264     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.8.9.871     Document Type: Review

References (59)

1. Baba, M., S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski, and T. Iwatsubo. 1998. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152: 879-884.
2. Bennett, P. and D.J. Nicholl. 1998. Absence of the G209A mutation in the α-synuclein gene in British families with Parkinson's disease. Neurology 50: 1183.
3. Campion, D., C. Martin, R. Heilig, F. Charbonnier, V. Moreau, J.M. Flaman, J.L. Petit, D. Hannequin, A. Brice, and T. Frebourg. 1995. The NACP/synuclein gene: Chromosomal assignment and screening for alterations in Alzheimer disease. Genomics 26: 254-257.
4. Chan, P., X. Jiang, L.S. Forno, D.A. Di Monte, C.M. Tanner, and J.W. Langston. 1998. Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease. Neurology 50: 1136-1137.
5. Chen, X., H.A. de Silva, M.J. Pettenati, P.N. Rao, P. St.George-Hyslop, A.D. Roses, Y. Xia, K. Horsburgh, K. Ueda, and T. Saitoh. 1995. The human NACP/α-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis. Genomics 26: 425-427.
6. Colley, W.C., T.C. Sung, R. Roll, J. Jenco, S.M. Hammond, Y. Altshuller, D. Bar-Sagi, A.J. Morris, and M.A. Frohman. 1997. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7: 191-201.
7. Davidson, W.S., A. Jonas, D.F. Clayton and J.M. George. 1998. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273: 9443-9449.
8. Farrer, M., F. Wavrant-De Vrieze, R. Crook, L. Boles, J. Perez-Tur, J. Hardy, W.G. Johnson, J. Steele, D. Maraganore, K. Gwinn, and T. Lynch. 1998. Low frequency of α-synuclein mutations in familial Parkinson's disease. Ann. Neurol. 43: 394-397.
9. George, J.M., H. Jin, W.S. Woods, and D.F. Clayton. 1995. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15: 361-372.
10. Han, H., P.H. Weinreb, and P.T. Lansbury, Jr. 1995. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2: 163-169.
11. Hashimoto, M., M. Yoshimoto, A. Sisk, L.J. Hsu, M. Sundsmo, A. Kittel, T. Saitoh, A. Miller, and E. Masliah. 1997. NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation. Biochem. Biophys. Res. Commun. 237: 611-616.
12. Hashimoto, M., L.J. Hsu, A. Sisk, Y. Xia, A. Takeda, M. Sundsmo, and E. Masliah. 1998. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res. 799: 301-306.
13. Hong, L., H.W. Ko, B.J. Gwag, E. Joe, S. Lee, Y.T. Kim, and Y.H. Suh. 1998. The cDNA cloning and ontogeny of mouse α-synuclein. Neuroreport 9: 1239-1243.
14. Hsu, L.J., M. Mallory, Y. Xia, I. Veinbergs, M. Hashimoto, M. Yoshimoto, L.J. Thai, T. Saitoh, and E. Masliah. 1998. Expression pattern of synucleins (non-Aβ component of Alzheimer's disease amyloid precursor protein/α-synuclein) during murine brain development. J. Neurochem. 71: 338-344.
15. Irizarry, M.C., T.W. Kim, M. McNamara, R.E. Tanzi, J.M. George, D.F. Clayton, and B.T. Hyman. 1996. Characterization of the precursor protein of the non-A β component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol. 55: 889-895.
16. Irizarry, M.C., W. Growdon, T. Gomez-Isla, K. Newell, J.M. George, D.F. Clayton, and B.T. Hyman. 1998. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57: 334-337.
17. Iwai, A., E. Masliah, M. Yoshimoto, N. Ge, L. Flanagan, H.A. de Silva, A. Kittel, and T. Saitoh. 1995a. The precursor protein of non-A β component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467-475.
18. Iwai, A., M. Yoshimoto, E. Masliah, and T. Saitoh. 1995b. Non-A β component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34: 10139-10145.
19. Iwai, A., E. Masliah, M.P. Sundsmo, R. DeTeresa, M. Mallory, D.P. Salmon, and T. Saitoh. 1996. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease. Brain Res. 720: 230-234.
20. Iwatsubo, T., H. Yamaguchi, M. Fujimuro, H. Yokosawa, Y. Ihara, J.Q. Trojanowski, and V.M. Lee. 1996. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148: 1517-1529.
21. Jakes, R., M.G. Spillantini, and M. Goedert. 1994. Identification of two distinct synucleins from human brain. FEBS Lett. 345: 27-32.
22. Jenco, J.M., A. Rawlingson, B. Daniels, and A.J. Morris. 1998. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins. Biochemistry 37: 4901-4909.
23. Jensen, P.H., P. Hojrup, H. Hager, M.S. Nielsen, L. Jacobsen, O.F. Olesen, J. Gliemann, and R. Jakes. 1997. Binding of Aβ to α- and β-synucleins: Identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC. Biochem. J. 323: 539-546.
24. Ji, H., Y.E. Liu, T. Jia, M. Wang, J. Liu, G. Xiao, B.K. Joseph, C. Rosen, and Y.E. Shi. 1997. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 57: 759-764.
25. Kruger, R., W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess. 1998. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18: 106-108.
26. Lansbury, P.T. Jr. 1997. Structural neurology: Are seeds at the root of neuronal degeneration? Neuron 19: 1151-1154.
27. Lavedan, C., A. Dehejia, B. Pike, A. Dutra, E. Leroy, S.E. Ide, H. Root, J. Rubenstein, R.L. Boyer, S. Chandrasekharappa, et al. 1998a. Contig map of the Parkinson's disease region on 4q21-q23. DNA Res. 5: 1-5.
28. Lavedan, C., E. Leroy, A. Dehejia, S. Buchholtz, A. Dutra, R.L. Nussbaum and M.H. Polymeropoulos. 1998b. Identification, localization and characterization of the human γ-synuclein gene. Hum. Genet. 103: 106-112.
29. Maroteaux, L. and R.H. Scheller. 1991. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Mol. Brain Res. 11: 335-343.
30. Maroteaux, L., J.T. Campanelli and R.H. Scheller. 1988. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8: 2804-2815.
31. Masliah, E., A. Iwai, M. Mallory, K. Ueda, and T. Saitoh. 1996. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am. J. Pathol. 148: 201-210.
32. Mezey, E., A. Dehejia, G. Harta, M.I. Papp, M.H. Polymeropoulos, and M.J. Brownstein. 1998a. α Synuclein in neurodegenerative disorders: murderer or accomplice? Nat. Med. 4: 755-757.
33. Mezey, E., A.M Dehejia, G. Harta, S.F. Suchy, R.L. Nussbaum, M.J. Brownstein, and M.H. Polymeropoulos. 1998b. α Synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol. Psychiatry (in press).
34. Munoz, E., R. Oliva, V. Obach, M.J. Marti, P. Pastor, F. Ballesta, and E. Tolosa. 1997. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients. Neurosci. Lett. 235: 57-60.
35. Nakajo, S., K. Omata, T. Aiuchi, T. Shibayama, I. Okahashi, H. Ochiai, Y. Nakai, K. Nakaya, and Y. Nakamura. 1990. Purification and characterization of a novel brain-specific 14-kDa protein. J. Neurochem. 55: 2031-2038.
36. Nakajo, S., K. Tsukada, K. Omata, Y. Nakamura, and K. Nakaya. 1993. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur. J. Biochem. 217: 1057-1063.
37. Nussbaum, R.L. and M.H. Polymeropoulos. 1997. Genetics of Parkinson's disease. Hum. Mol. Genet. 6: 1687-1691.
38. Paik, S.R., J.H. Lee, D.H. Kim, C.S. Chang, and Y.S. Kim. 1998. Self-oligomerization of NACP, the precursor protein of the non-amyloid β/A4 protein (A β) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A β fragment (residues 25-35). FEBS Lett. 421: 73-76.
39. Polymeropoulos, M.H., C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer et al. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
40. Segrest, J.P., H. De Loof, J.G. Dohlman, C.G. Brouillette, and G.M. Anantharamaiah. 1990. Amphipathic helix motif: Classes and properties. Proteins 8: 103-117.
41. Segrest, J.P., M.K. Jones, H. De Loof, C.G. Brouillette, Y.V. Venkatachalapathi, and G.M. Anantharamaiah. 1992. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J. Lipid. Res. 33: 141-166.
42. Shibasaki, Y., D.A. Baillie, D. St. Clair, and A.J. Brookes. 1995. High-resolution mapping of SNCA encoding α-synuclein, the non-A β component of Alzheimer's disease amyloid precursor, to human chromosome 4q21.3 → q22 by fluorescence in situ hybridization. Cytogenet. Cell Genet. 71: 54-55.
43. Shibayama-Imazu, T., I. Okahashi, K. Omata, S. Nakajo, H. Ochiai, Y. Nakai, T. Hama, Y. Nakamura, and K. Nakaya. 1993. Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res. 622: 17-25.
44. Shibayama-Imazu, T., K. Ogane, Y. Hasegawa, S. Nakajo, S. Shioda, H. Ochiai, Y. Nakai, and K. Nakaya. 1998. Distribution of PNP 14 (β-synuclein) in neuroendocrine tissues: localization in Sertoli cells. Mol. Reprod. Dev. 50: 163-169.
45. Spillantini, M.G., A. Divane, and M. Goedert. 1995. Assignment of human α-synuclein (SNCA) and β-synuclein (SNCB) genes to chromosomes 4q21 and 5q35. Genomics 27: 379-381.
46. Spillantini, M.G., M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert. 1997. α-Synuclein in Lewy bodies. Nature 388: 839-840.
47. Spillantini, M.G., R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert. 1998. α-synuclein in filamentous inclusions of lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. 95: 6469-6473.
48. Takeda, A., M. Mallory, M. Sundsmo, W. Honer, L. Hansen, and E. Masliah. 1998. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am. J. Pathol. 152: 367-372.
49. Tobe, T., S. Nakajo, A. Tanaka, A. Mitoya, K. Omata, K. Nakaya, M. Tomita, and Y. Nakamura. 1992. Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein. J. Neurochem. 59: 1624-1629.
50. Ueda, K., H. Fukushima, E. Masliah, Y. Xia, A. Iwai, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara, and T. Saitoh. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. 90: 11282-11286.
51. Ueda, K., T. Saitoh, and H. Mori. 1994. Tissue-dependent alternative splicing of messenger-RNA for NACP, the precursor of non-A-β component of Alheimer's disease amyloid. Biochem. Biophys. Res. Commun. 205: 1366-1372.
52. van Leeuwen, F.W., D.P. de Kleijn, H.H. van den Hurk, A. Neubauer, M.A. Sonnemans, J.A. Sluijs, S. Koycu, R.D.J. Ramdjielal, A. Salehi, G.J.M. Martens et al. 1998. Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279: 242-247.
53. Vaughan, J.R., M. Farrer, Z.K. Wszolek, T. Gasser, A. Durr, Y. Agid, V. Bonifati, G. DeMichele, G. Volpe, S. Lincoln et al. 1998. Sequencing of the α-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. Hum. Mol. Genet. 7: 751-753.
54. Wakabayashi, K., K. Matsumoto, K. Takayama, M. Yoshimoto, and H. Takahashi. 1997. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 359: 45-48.
55. Weinreb, P.H., W. Zhen, A.W. Poon, K.A. Conway, and P.T. Lansbury Jr. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35: 13709-13715.
56. Withers, G.S., J.M. George, G.A. Banker, and D.F. Clayton. 1997. Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Dev. Brain Res. 99: 87-94.
57. Xia, Y., H.A. Rohan de Silva, B.L. Rosi, L.H. Yamaoka, J.B. Rimmler, M.A. Pericak-Vance, A.D. Roses, X. Chen, E. Masliah, R. DeTeresa et al. 1996. Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism. Ann. Neurol. 40: 207-215.
58. Yoshimoto, M., A. Iwai, D. Kang, D.A. Otero, Y. Xia, and T. Saitoh. 1995. NACP, the precursor protein of the non-amyloid β/A4 protein (A β) component of Alzheimer disease amyloid, binds A β and stimulates A β aggregation. Proc. Natl. Acad. Sci. 92: 9141-9145.
59. Zareparsi, S., J. Kay, R. Camicioli, P. Kramer, J. Nutt, T. Bird, M. Litt, and H. Payami. 1998. Analysis of the α-synuclein G209A mutation in familial Parkinson's disease. Lancet 351: 37-38.